Anti-CD14 Treatment in Patients With Severe COVID-19 Clinical and Biological Effects in a Phase 2 Randomized Open-Label Adaptive Platform Clinical Trial
Titel:
Anti-CD14 Treatment in Patients With Severe COVID-19 Clinical and Biological Effects in a Phase 2 Randomized Open-Label Adaptive Platform Clinical Trial
Auteur:
Mabrey, F. Linzee Martin, Thomas R. Calfee, Carolyn S. Liu, Kathleen D. LaCombe, Benjamin Brown-Swigart, Lamorna Discacciati, Andrea Eklund, Martin Heckbert, Susan R. Matthay, Michael A. Esserman, Laura Wurfel, Mark M.